The development of a novel series of (quinolin-2-ylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 3. Structural variation of the acidic side chain to give antagonists of enhanced potency.

Source:http://linkedlifedata.com/resource/pubmed/id/2170649

Download in:

View as

General Info

PMID
2170649